دورية أكاديمية
أعرض في EDS

Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.

التفاصيل البيبلوغرافية
العنوان: Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.
المؤلفون: Park BJ; Division of Thoracic Surgery, Hackensack University Medical Center, Hackensack, NJ 07601, USA. bpark@humed.com, Melfi F, Mussi A, Maisonneuve P, Spaggiari L, Da Silva RK, Veronesi G
المصدر: The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2012 Feb; Vol. 143 (2), pp. 383-9. Date of Electronic Publication: 2011 Nov 20.
نوع المنشور: Journal Article; Multicenter Study
اللغة: English
بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0376343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-685X (Electronic) Linking ISSN: 00225223 NLM ISO Abbreviation: J Thorac Cardiovasc Surg Subsets: MEDLINE
أسماء مطبوعة: Publication: St. Louis, MO : Mosby
Original Publication: St. Louis.
مواضيع طبية MeSH: Robotics* , Surgery, Computer-Assisted*/adverse effects , Surgery, Computer-Assisted*/mortality , Thoracic Surgery, Video-Assisted*/adverse effects , Thoracic Surgery, Video-Assisted*/mortality, Carcinoma, Non-Small-Cell Lung/*surgery , Lung Neoplasms/*surgery , Pneumonectomy/*methods, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Hospital Mortality ; Humans ; Italy ; Kaplan-Meier Estimate ; Length of Stay ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Pneumonectomy/adverse effects ; Pneumonectomy/mortality ; Retrospective Studies ; Survival Rate ; Time Factors ; Treatment Outcome
مستخلص: Objective(s): We evaluated a large series of patients undergoing robotic lobectomy for the treatment of early-stage non-small cell lung cancer (NSCLC) to assess long-term oncologic efficacy.
Methods: A multi-institutional retrospective review of patients undergoing robotic lobectomy for NSCLC was performed. Robotic lobectomy was performed in a manner consistent with the Cancer and Leukemia Group B (CALGB) consensus video-assisted thoracic surgery (VATS) lobectomy technique using a robotic surgical system. Perioperative outcomes and long-term follow-up were recorded prospectively, and survival was calculated from the date of surgery to last follow-up.
Results: From November 2002 through May 2010, a total of 325 consecutive patients underwent robotic lobectomy for early-stage NSCLC at 3 institutions. The median age of patients was 66 years (range, 30-87 years), and 37% (120) were female. The majority were in clinical stage I (IA, 247; IB, 63). Conversion rate to thoracotomy was 8% (27/325). Overall morbidity rate was 25.2% (82/325), and major complication rate was 3.7% (12/325). There was 1 in-hospital death (0.3%), and the median length of stay was 5 days (range, 2-28 days). Pathologic stage distribution was 54% (176) IA, 22% (72) IB, 13% (41) IIA, 5% (15) IIB, and 6% (21) IIIA. With a median follow-up of 27 months, overall 5-year survival was 80% (95% confidence intervals [CI] = 73-88), and by pathologic stage, 91% (CI = 83-99) for stage IA, 88% (CI = 77-98) for stage IB, and 49% (CI = 24-74) for all patients with stage II disease. Overall 3-year survival for patients with stage IIIA disease was 43% (CI = 16-69).
Conclusions: Robotic lobectomy for early-stage NSCLC can be performed with low morbidity and mortality. Long-term stage-specific survival is acceptable and consistent with prior results for VATS and thoracotomy.
(Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.)
تواريخ الأحداث: Date Created: 20111123 Date Completed: 20120228 Latest Revision: 20220408
رمز التحديث: 20240628
DOI: 10.1016/j.jtcvs.2011.10.055
PMID: 22104677
قاعدة البيانات: MEDLINE
الوصف
تدمد:1097-685X
DOI:10.1016/j.jtcvs.2011.10.055